Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Swiss Transplant Cohort Study (STCS)

This study is currently recruiting participants. (see Contacts and Locations)
Verified December 2015 by University of Zurich
University of Bern
University of Basel
University of Lausanne
Cantonal Hospital of St. Gallen
University Hospital, Geneva
Information provided by (Responsible Party):
Nicolas Mueller, University of Zurich Identifier:
First received: September 16, 2010
Last updated: December 2, 2015
Last verified: December 2015
The Swiss Transplant Cohort Study is an observational prospective cohort study enrolling all patients after solid organ and stem cell transplantation since 5/2008 in Switzerland. Predefined variables are collected at defined time points. Individual samples (PBMC, plasma, DNA) will be stored for future projects. Data relevant to transplantation outcome with emphasis on immunological and infectious complications as well as psychosocial variables will be gathered.

All Transplanted Individuals in Switzerland

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Swiss Transplant Cohort Study

Further study details as provided by University of Zurich:

Primary Outcome Measures:
  • Outcome after transplantation [ Time Frame: open ] [ Designated as safety issue: No ]
    Various endpoints

Estimated Enrollment: 100
Study Start Date: May 2008
Estimated Study Completion Date: May 2018
Estimated Primary Completion Date: May 2018 (Final data collection date for primary outcome measure)

Ages Eligible for Study:   up to 100 Years   (Child, Adult, Senior)
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
All transplanted indivduals in Switzerland

Inclusion criteria:

  • All patients after organ and stem cell (planned 2009) transplantation.

Exclusion criteria:

  • No informed consent given
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT01204944

Contact: 01 Studienregister MasterAdmins +41 (0)44 255 11 11

Zurich, Switzerland
Sponsors and Collaborators
University of Zurich
University of Bern
University of Basel
University of Lausanne
Cantonal Hospital of St. Gallen
University Hospital, Geneva
Study Director: 01 Studienregister MasterAdmins UniversitaetsSpital Zuerich
  More Information

Responsible Party: Nicolas Mueller, Head, Zurich University Hospital Transplant Center, University of Zurich Identifier: NCT01204944     History of Changes
Other Study ID Numbers: 3347C0-108795/1 
Study First Received: September 16, 2010
Last Updated: December 2, 2015
Health Authority: Switzerland: Swissmedic processed this record on October 25, 2016